Sales 2025 by Business Segment

Sales 2025 by Geography

Historical Breakdown of Revenue by Business Segments

Net Income: Breakdown by Business Segment

Breakdown by Business Segment (USD)
Fiscal Period: December 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Biological Products

          

Pharmaceuticals

75.44M 99.77M 199M 286M 349M

Total Assets

321M 295M 475M 394M 792M

Interest Expense

-16.58M -24.77M -25.16M -37.98M -38.03M

Income Tax Expense

- - 1.56M 2.93M -4.46M

CAPEX

-11.47M -7.59M -42.44M -9.69M -4.57M

EBT

-80.93M -87.4M -10.38M 30.52M 1.41M

D&A

5.1M 8.68M 5.84M 9.04M 12.28M

Operating Income

-47.02M -64.11M 8.68M 72.59M 38.8M

Net Income

-80.93M -87.4M -11.94M 27.59M 5.86M

Geographical Revenue Distribution History

Geographical breakdown of sales (USD)
Fiscal Period: December 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

United States of America

75.44M 99.77M 199M 286M 349M

Total Assets

321M 295M 475M 394M 792M

Interest Expense

-16.58M -24.77M -25.16M -37.98M -38.03M

Income Tax Expense

- - 1.56M 2.93M -4.46M

D&A

5.1M 8.68M 5.84M 9.04M 12.28M

CAPEX

-11.47M -7.59M -42.44M -9.69M -4.57M

Net Income

-80.93M -87.4M -11.94M 27.59M 5.86M

EBT

-80.93M -87.4M -10.38M 30.52M 1.41M

Operating Income

-47.02M -64.11M 8.68M 72.59M 38.8M